143 related articles for article (PubMed ID: 30194682)
1. Simultaneously Improving Mechanical, Formulation, and In Vivo Performance of Naproxen by Co-Crystallization.
Abbas N; Latif S; Afzal H; Arshad MS; Hussain A; Sadeeqa S; Bukhari NI
AAPS PharmSciTech; 2018 Oct; 19(7):3249-3257. PubMed ID: 30194682
[TBL] [Abstract][Full Text] [Related]
2. Development of paracetamol-caffeine co-crystals to improve compressional, formulation and in vivo performance.
Latif S; Abbas N; Hussain A; Arshad MS; Bukhari NI; Afzal H; Riffat S; Ahmad Z
Drug Dev Ind Pharm; 2018 Jul; 44(7):1099-1108. PubMed ID: 29385849
[TBL] [Abstract][Full Text] [Related]
3. Physicomechanical, stability, and pharmacokinetic evaluation of aceclofenac dimethyl urea cocrystals.
Afzal H; Abbas N; Hussain A; Latif S; Fatima K; Arshad MS; Bukhari NI
AAPS PharmSciTech; 2021 Feb; 22(2):68. PubMed ID: 33564940
[TBL] [Abstract][Full Text] [Related]
4. Spray drying of naproxen and naproxen sodium for improved tableting and dissolution - physicochemical characterization and compression performance.
Al-Zoubi N; Odeh F; Partheniadis I; Gharaibeh S; Nikolakakis I
Pharm Dev Technol; 2021 Feb; 26(2):193-208. PubMed ID: 33211618
[TBL] [Abstract][Full Text] [Related]
5. Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state.
Bettinetti G; Mura P; Faucci MT; Sorrenti M; Setti M
Eur J Pharm Sci; 2002 Feb; 15(1):21-9. PubMed ID: 11803128
[TBL] [Abstract][Full Text] [Related]
6. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions.
Zhu Q; Toth SJ; Simpson GJ; Hsu HY; Taylor LS; Harris MT
J Phys Chem B; 2013 Feb; 117(5):1494-500. PubMed ID: 23320811
[TBL] [Abstract][Full Text] [Related]
8. Formulation of co-amorphous systems from naproxen and naproxen sodium and in situ monitoring of physicochemical state changes during dissolution testing by Raman spectroscopy.
Ueda H; Peter Bøtker J; Edinger M; Löbmann K; Grohganz H; Müllertz A; Rades T; Østergaard J
Int J Pharm; 2020 Sep; 587():119662. PubMed ID: 32682958
[TBL] [Abstract][Full Text] [Related]
9. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer.
Fatima K; Bukhari NI; Latif S; Afzal H; Hussain A; Shamim R; Abbas N
Drug Dev Ind Pharm; 2021 Mar; 47(3):498-508. PubMed ID: 33646919
[TBL] [Abstract][Full Text] [Related]
11. Improving mechanical properties of desloratadine via multicomponent crystal formation.
Ainurofiq A; Mauludin R; Mudhakir D; Umeda D; Soewandhi SN; Putra OD; Yonemochi E
Eur J Pharm Sci; 2018 Jan; 111():65-72. PubMed ID: 28958892
[TBL] [Abstract][Full Text] [Related]
12. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique.
Nokhodchi A; Maghsoodi M
AAPS PharmSciTech; 2008; 9(1):54-9. PubMed ID: 18446461
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.
Khan FM; Ahmad M; Idrees HA
Drug Des Devel Ther; 2020; 14():4303-4313. PubMed ID: 33116417
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
Helmy SA; El Bedaiwy HM
Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
[TBL] [Abstract][Full Text] [Related]
15. Engineering of Naproxen Loaded Polymer Hybrid Enteric Microspheres for Modified Release Tablets: Development, Characterization, in silico Modelling and in vivo Evaluation.
Hameed HA; Khan S; Shahid M; Ullah R; Bari A; Ali SS; Hussain Z; Sohail M; Khan SU; Htar TT
Drug Des Devel Ther; 2020; 14():27-41. PubMed ID: 32021089
[TBL] [Abstract][Full Text] [Related]
16. Novel drug-drug salt crystals of metformin with ibuprofen or naproxen: Improved solubility, dissolution rate, and synergistic antinociceptive effects.
Qin HM; Luo ZK; Zhou HL; Zhu J; Xiao XY; Xiao Y; Zhuang T; Zhang GS
Int J Pharm; 2024 May; 657():124126. PubMed ID: 38626845
[TBL] [Abstract][Full Text] [Related]
17. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets.
Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
Drug Dev Ind Pharm; 2016 Aug; 42(8):1225-33. PubMed ID: 26555927
[TBL] [Abstract][Full Text] [Related]
18. In vitro dissolution profile comparison of an anti-migraine combinational drug in dosage form.
Hiremath VB; Kaliaperumal K; Bhojraj S; Nanjan MJ
Se Pu; 2010 Jan; 28(1):93-9. PubMed ID: 20458929
[TBL] [Abstract][Full Text] [Related]
19. Naproxen glycine conjugate-synthesis, pharmaceutical preformulation and pharmacodynamic evaluation.
Mishra A; Agrawal S; Pathak K
Drug Deliv; 2012 Feb; 19(2):102-11. PubMed ID: 22239596
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation.
Allesø M; Chieng N; Rehder S; Rantanen J; Rades T; Aaltonen J
J Control Release; 2009 May; 136(1):45-53. PubMed ID: 19331842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
